Safety and efficacy of 1-month dual antiplatelet therapy in high bleeding and ischemic risk elderly patients with coronary artery disease after implantation of zotarolimus-eluting coronary stent system (Resolute Onyx™ , Medtronic, Minneapolis, MN); A multicenter, prospective, observational study
Not Applicable
Recruiting
- Conditions
- Factors influencing health status and contact with health services
- Registration Number
- KCT0008377
- Lead Sponsor
- Pusan National University Yangsan Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 500
Inclusion Criteria
75 years of age or older who underwent percutaneous coronary intervention using Resolute Onyx stents an aged patient.
Exclusion Criteria
- If DAPT therapy cannot be followed for a month
- If additional surgery is required
- If you have a non-cardiac comorbid disease with a life expectancy of less than one year
- If there is a taboo against aspirin or P2Y12 inhibitors
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method